Beta Bionics (BBNX) Treasury Shares (2023 - 2024)
Beta Bionics' (BBNX) quarterly Treasury Shares came in at $17.2 million in Q4 2024, up 33.8% year-over-year from $12.9 million in Q1 2024, and up 33.8% quarter-over-quarter from $12.9 million in Q3 2024.
Analysis
Beta Bionics (BBNX) Treasury Shares (2023 - 2024) Analysis & Trends
Beta Bionics has disclosed Treasury Shares across 2 years of filings, most recently posting $17.2 million for Q4 2024.
- In Q4 2024, Treasury Shares rose 33.8% year-over-year to $17.2 million; the TTM figure through Dec 2024 stood at $17.2 million (up 33.8% YoY), while the FY2024 annual figure was $17.2 million, up 33.8% from the prior year.
- Treasury Shares came in at $17.2 million for Q4 2024 at Beta Bionics, up from $12.9 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $17.2 million in Q4 2024 to a low of $12.9 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 267.91 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 303.21 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.67 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 35.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 17.23 Mn |
| Dec 31, 2024 | 17.23 Mn |
| Sep 30, 2024 | 12.88 Mn |
| Sep 30, 2024 | 12.88 Mn |
| Jun 30, 2024 | 12.88 Mn |
| Jun 30, 2024 | 12.88 Mn |
| Mar 31, 2024 | 12.88 Mn |
| Mar 31, 2024 | 12.88 Mn |
| Dec 31, 2023 | 12.88 Mn |
| Dec 31, 2023 | 12.88 Mn |